Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome

Background. Adiponectin acts to prevent vascular dysfunction due to obesity by inhibiting ICAM-1 and VCAM-1 expressions. Objective. We investigate adiponectin ICAM-1, VCAM-1, and metabolic syndrome (MetS) in obese adolescents. Methods. A cross-sectional study with healthy obese adolescents aged 13 t...

Full description

Saved in:
Bibliographic Details
Main Authors: Nur Aisiyah Widjaja, Leonardo Alexander Caesar, Suhasta Nova, Eva Ardianah
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2023/4574042
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404602887176192
author Nur Aisiyah Widjaja
Leonardo Alexander Caesar
Suhasta Nova
Eva Ardianah
author_facet Nur Aisiyah Widjaja
Leonardo Alexander Caesar
Suhasta Nova
Eva Ardianah
author_sort Nur Aisiyah Widjaja
collection DOAJ
description Background. Adiponectin acts to prevent vascular dysfunction due to obesity by inhibiting ICAM-1 and VCAM-1 expressions. Objective. We investigate adiponectin ICAM-1, VCAM-1, and metabolic syndrome (MetS) in obese adolescents. Methods. A cross-sectional study with healthy obese adolescents aged 13 to 18 years was conducted from October 2019 to January 2020. Statistical analysis conducted was a test of normality and homogeneity tests, ANOVA/Kruskal–Wallis, independent sample T-test/Mann–Whitney U test, and Spearman correlation and determined as significant if p value <0.05. Results. 125 obese adolescents were recruited. 42 (33.6%) were obese with MetS (we grouped as MetS) and 83 (66.4%) subjects without MetS (non-MetS group). VCAM-1 was significantly higher on boys with MetS compared to girls with MetS, and even girls with MetS had lower levels of VCAM-1 than boys with non-MetS. ICAM-1 was significantly higher in boys with low-level HDL-c (p<0.05) and correlated weakly with HDL-c, while adiponectin levels were significantly lower in girls with central obesity and hypertriglyceridemia. Path analysis showed that triglyceride had a direct effect on ICAM-1 but not VCAM-1 in both obese boys and girls. Adiponectin had a negative direct effect on ICAM-1 and VCAM-1 in girls. However, on boys, diastole blood pressure had a negative direct effect, which might be the role of sex hormones indirectly. Conclusion. VCAM-1 was significantly higher in boys than girls, which showed that boys had a higher risk of atherosclerosis. ICAM-1 showed no significant difference in both gender and metabolic states. Adiponectin showed a protective effect by lowering ICAM-1 and VCAM-1 directly on girls.
format Article
id doaj-art-9b87cf707d304842bf013dfda20be5f7
institution Kabale University
issn 2090-0716
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-9b87cf707d304842bf013dfda20be5f72025-08-20T03:36:57ZengWileyJournal of Obesity2090-07162023-01-01202310.1155/2023/4574042Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic SyndromeNur Aisiyah Widjaja0Leonardo Alexander Caesar1Suhasta Nova2Eva Ardianah3Faculty of MedicineFaculty of MedicineFaculty of MedicineIkatan Dokter Indonesia SurabayaBackground. Adiponectin acts to prevent vascular dysfunction due to obesity by inhibiting ICAM-1 and VCAM-1 expressions. Objective. We investigate adiponectin ICAM-1, VCAM-1, and metabolic syndrome (MetS) in obese adolescents. Methods. A cross-sectional study with healthy obese adolescents aged 13 to 18 years was conducted from October 2019 to January 2020. Statistical analysis conducted was a test of normality and homogeneity tests, ANOVA/Kruskal–Wallis, independent sample T-test/Mann–Whitney U test, and Spearman correlation and determined as significant if p value <0.05. Results. 125 obese adolescents were recruited. 42 (33.6%) were obese with MetS (we grouped as MetS) and 83 (66.4%) subjects without MetS (non-MetS group). VCAM-1 was significantly higher on boys with MetS compared to girls with MetS, and even girls with MetS had lower levels of VCAM-1 than boys with non-MetS. ICAM-1 was significantly higher in boys with low-level HDL-c (p<0.05) and correlated weakly with HDL-c, while adiponectin levels were significantly lower in girls with central obesity and hypertriglyceridemia. Path analysis showed that triglyceride had a direct effect on ICAM-1 but not VCAM-1 in both obese boys and girls. Adiponectin had a negative direct effect on ICAM-1 and VCAM-1 in girls. However, on boys, diastole blood pressure had a negative direct effect, which might be the role of sex hormones indirectly. Conclusion. VCAM-1 was significantly higher in boys than girls, which showed that boys had a higher risk of atherosclerosis. ICAM-1 showed no significant difference in both gender and metabolic states. Adiponectin showed a protective effect by lowering ICAM-1 and VCAM-1 directly on girls.http://dx.doi.org/10.1155/2023/4574042
spellingShingle Nur Aisiyah Widjaja
Leonardo Alexander Caesar
Suhasta Nova
Eva Ardianah
Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
Journal of Obesity
title Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
title_full Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
title_fullStr Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
title_full_unstemmed Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
title_short Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome
title_sort beyond the scale investigating adiponectin icam 1 and vcam 1 as metabolic markers in obese adolescents with metabolic syndrome
url http://dx.doi.org/10.1155/2023/4574042
work_keys_str_mv AT nuraisiyahwidjaja beyondthescaleinvestigatingadiponectinicam1andvcam1asmetabolicmarkersinobeseadolescentswithmetabolicsyndrome
AT leonardoalexandercaesar beyondthescaleinvestigatingadiponectinicam1andvcam1asmetabolicmarkersinobeseadolescentswithmetabolicsyndrome
AT suhastanova beyondthescaleinvestigatingadiponectinicam1andvcam1asmetabolicmarkersinobeseadolescentswithmetabolicsyndrome
AT evaardianah beyondthescaleinvestigatingadiponectinicam1andvcam1asmetabolicmarkersinobeseadolescentswithmetabolicsyndrome